CytoDyn Inc. (CYDY)

CytoDyn Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	461	427	157	239	231	1,188
Market Cap Growth	62.78%	172.64%	-34.59%	3.83%	-80.59%	-22.02%
Enterprise Value	474	438	186	271	266	1,213
Last Close Price	0.34	0.34	0.16	0.26	0.32	1.90
PE Ratio	-	188.79	-	-	-	-
PS Ratio	-	-	-	-	867.10	-
PB Ratio	-4.42	-4.45	-1.34	-2.19	-2.44	-56.52
EV/Sales Ratio	-	-	-	-	998.20	-
EV/EBITDA Ratio	-	45.25	-	-	-	-
EV/EBIT Ratio	-	45.33	-	-	-	-
Debt / Equity Ratio	-0.28	-0.28	-0.26	-0.32	-0.39	-3.02
Debt / EBITDA Ratio	-	2.80	-	-	-	-
Net Debt / Equity Ratio	-0.13	-0.16	-0.23	-0.30	-0.34	-1.40
Net Debt / EBITDA Ratio	-0.61	1.60	-1.50	-0.82	-0.22	-0.32
Net Debt / FCF Ratio	-0.73	-1.76	-2.45	-1.31	-0.42	-0.25
Asset Turnover	-	-	-	-	0.00	-
Quick Ratio	0.31	0.20	0.04	0.02	0.03	0.22
Current Ratio	0.37	0.25	0.13	0.09	0.09	0.24
Return on Assets (ROA)	-67.45%	41.38%	-100.64%	-125.31%	-112.71%	-64.72%
Return on Capital Employed (ROCE)	67.10%	-18.40%	24.70%	37.40%	154.70%	462.00%
Earnings Yield	-8.73%	0.88%	-31.82%	-33.33%	-91.40%	-14.85%
FCF Yield	-	-2.05%	-7.01%	-10.48%	-33.70%	-9.91%
Buyback Yield / Dilution	-9.37%	-28.20%	-15.90%	-23.58%	-15.20%	-39.54%

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.